Akari Therapeutics ADR
(AKTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 13,250 | 8,151 | 16,723 | 9,361 |
| Other current assets | 0 | 565 | 3,201 | 2,711 | 2,264 |
| TOTAL | $N/A | $13,815 | $11,352 | $19,433 | $11,625 |
| Non-Current Assets | |||||
| Intangibles | 0 | 0 | 0 | 21 | 23 |
| Other Non-Current Assets | 0 | 17 | 19 | 0 | 0 |
| TOTAL | $N/A | $17 | $19 | $21 | $23 |
| Total Assets | $N/A | $13,832 | $11,371 | $19,455 | $11,648 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 947 | 1,635 | 3,076 | 1,789 |
| Accrued Expenses | N/A | 3,148 | 1,411 | 2,448 | 3,185 |
| Other current liabilities | N/A | 7,946 | N/A | N/A | 1,120 |
| TOTAL | $N/A | $12,041 | $3,045 | $5,524 | $6,093 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $N/A | $12,041 | $3,045 | $5,524 | $6,093 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 3,722 | N/A | N/A | N/A |
| Common Shares | N/A | 745 | 594 | 594 | 476 |
| Retained earnings | N/A | -217,453 | -210,561 | -204,881 | -199,705 |
| Other shareholders' equity | 0 | 51,423 | 51,572 | 51,620 | 51,653 |
| TOTAL | $N/A | $1,791 | $8,326 | $13,931 | $5,555 |
| Total Liabilities And Equity | $0 | $13,832 | $11,371 | $19,455 | $11,648 |